Categories: Technology

SoundHound AI Establishes New Innovation Hub in Bengaluru to Accelerate Global Agentic AI Expansion

SANTA CLARA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) — SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice and conversational AI, today announced the opening of its new state-of-the-art innovation hub in Bengaluru, India. The expansion marks a significant milestone in the company’s evolution to scale agentic AI globally, positioning SoundHound at the epicenter of India’s rapidly accelerating AI economy.

The opening coincides with a period of historic momentum for the Indian technology sector. As the country reinforces its role as a global AI powerhouse, SoundHound’s new Bengaluru hub will serve as a critical engine for the company’s next wave of innovation, including continued advancement of its next generation agentic AI platform.

SoundHound provides enterprise-grade voice and conversational AI solutions across industries including retail, healthcare, financial services, automotive, restaurants, insurance, government, and more. Its agentic AI technology enables AI agents to collaborate seamlessly to complete complex, multi-step workflows across customer touchpoints – including voice, SMS, webchat, email, smart devices, social media, contact centers, and in-vehicle systems. Today, SoundHound powers millions of products and services worldwide, enabling billions of AI interactions each year for leading global brands.

With the addition of Bengaluru, SoundHound continues to expand its global footprint, joining offices in Beijing, Berlin, Franklin, MA, New Providence, NJ, New York, NY, Paris, Santa Clara, CA, Seoul, and Toronto.

Bengaluru is a global magnet for world-class AI talent, and our new office here is more than just a workspace, it’s an innovation hub where the future of human-to-AI interaction is being built,” said Keyvan Mohajer, CEO & Co-Founder of SoundHound AI.With the region’s increasing focus on digital transformation and intelligent automation, we are proud to deepen our roots in this ecosystem and contribute to the global AI revolution.”

For more information about SoundHound, please visit: https://www.soundhound.com/

About SoundHound AI
SoundHound AI (Nasdaq: SOUN), a global leader in voice and conversational AI, delivers solutions that allow businesses to offer superior experiences to their customers. Built on proprietary technology, SoundHound’s voice AI delivers best-in-class speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants. The company’s groundbreaking AI-driven products include Smart Answering, Smart Ordering, Dynamic Drive-Thru, and the Amelia Platform, which powers AI Agents for enterprise. In addition, SoundHound’s Agentic AI for Automotive and Autonomics, a category-leading operations platform that automates IT processes, have enabled SoundHound to power millions of products and services, and process billions of interactions each year for world-class businesses.

Media Contact:
Fiona McEvoy
415-610-6590
PR@SoundHound.com

GlobeNews Wire

Recent Posts

Crypto News: AlphaPepe Presale Records Surge in Whale Accumulation As Bitcoin Price Prediction Eyes $180,000

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

7 hours ago

Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after…

7 hours ago

Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery

SINGAPORE, May 16, 2026 (GLOBE NEWSWIRE) -- Qoder officially releases version 1.0, upgrading from an…

7 hours ago

Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction

Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically…

7 hours ago

ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026

– Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract…

7 hours ago

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast…

7 hours ago